Moller Financial Services Abb Vie Inc. Transaction History

Moller Financial Services

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $468,178 - $598,441	-7,126 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$77.85 - $96.01 $554,759 - $684,167	7,126 New	7,126 $604,000
Q4 2017 Jan 19, 2018	SELL	$89.56 - $98.21 $312,833 - $343,047	-3,493 Closed	0 $0
Q3 2017 Oct 26, 2017	BUY	$69.85 - $89.22 $243,986 - $311,645	3,493	3,493 $0

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Moller Financial Services, based on Form 13F filings with the SEC.

Stay updated on Moller Financial Services with notifications on news.